E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/6/2018 in the Prospect News Bank Loan Daily.

AmerisourceBergen restates $1.4 billion revolver, reprices term loan

By Wendy Van Sickle

Columbus, Ohio, Nov. 6 – AmerisourceBergen Corp. amended and restated its $1.4 billion multicurrency revolving credit facility on Oct. 31, extending the maturity date to Oct. 31, 2023, and refinanced its term credit agreement, according to an 8-K filing with the Securities and Exchange Commission.

Additionally, some restrictive covenants of the revolver were amended, including modifications made to allow for debt of foreign subsidies.

Revolver borrowings bear interest at Libor or CDOR plus an applicable rate based on the company’s debt ratings. The applicable rate ranges from 70 basis points to 110 bps. The commitment fee ranges from 5 bps to 15 bps and is also based on ratings.

There is a $75 million sublimit for letters of credit.

J.P. Morgan Securities LLC, Bank of America Merrill Lynch and Wells Fargo Securities LLC are the lead arrangers and joint bookrunners with JPMorgan Chase Bank, NA as administrative agent, Bank of America, NA and Wells Fargo Bank NA as syndication agents and Citibank, NA, Morgan Stanley Senior Funding, Inc., MUFG Bank Ltd., Bank of Nova Scotia and U.S. Bank NA as documentation agents.

The revolving credit agreement is originally dated March 18, 2011.

Proceeds of the revolver may be used for general corporate purposes.

The $400 million refinanced term loan has terms that are substantially similar terms the previous term loan agreement, originally dated Feb. 9, 2015, except that the interest rate is reduced to Libor plus 65 bps, and some changes were made to conform to amendments to the multicurrency revolver.

Wells Fargo is the lead arranger, bookrunner and administrative agent.

Based in Chesterbrook, Pa., AmerisourceBergen provides drug distribution and related services to pharmaceutical manufacturers in the United States and Canada.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.